CompletedPhase 3NCT01189448
Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Studying Congenital toxoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Laurent Mandelbrot, MDAssistance Publique Hopitaux de Paris
- Intervention
- Pyrimethamine/Sulfadiazine(drug)
- Enrollment
- 149 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2010 – 2016
Study locations (1)
- Hôpital Louis Mourier, Colombes, Hauts-de-Saine, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01189448 on ClinicalTrials.gov